Your browser doesn't support javascript.
loading
Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis.
Kako, Shinichi; Fujiwara, Shinichiro; Sato, Miki; Kimura, Shun-Ichi; Nakasone, Hideki; Ohashi, Kazuteru; Kawakita, Toshiro; Maeda, Tetsuo; Morishita, Takanobu; Suzuki, Ritsuro; Fukuda, Takahiro; Ichinohe, Tatsuo; Kurata, Mio; Atsuta, Yoshiko; Kanda, Yoshinobu.
Afiliación
  • Kako S; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Fujiwara S; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan.
  • Sato M; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Kimura SI; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Nakasone H; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
  • Ohashi K; Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan.
  • Kawakita T; Department of Hematology, National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Maeda T; Department of Hematology and Oncology, Osaka University Hospital, Osaka, Japan.
  • Morishita T; Department of Hematology, Japanese Red Cross Nagoya First Hospital, Nagoya, Japan.
  • Suzuki R; Department of Oncology/Hematology, Shimane University Hospital, Shimane, Japan.
  • Fukuda T; Hematopoietic Stem Cell Transplantation Division, National Cancer Center Hospital, Tokyo, Japan.
  • Ichinohe T; Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan.
  • Kurata M; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Atsuta Y; Japanese Data Center for Hematopoietic Cell Transplantation, Nagoya, Japan.
  • Kanda Y; Division of Hematology, Saitama Medical Center, Jichi Medical University, Saitama, Japan; Division of Hematology, Department of Medicine, Jichi Medical University, Shimotsuke, Japan. Electronic address: ycanda-tky@umin.ac.jp.
Biol Blood Marrow Transplant ; 24(10): 2139-2144, 2018 10.
Article en En | MEDLINE | ID: mdl-29680515
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Busulfano / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Acondicionamiento Pretrasplante / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Busulfano / Trasplante de Células Madre Hematopoyéticas / Neoplasias Hematológicas / Acondicionamiento Pretrasplante / Enfermedad Injerto contra Huésped / Trastornos Mieloproliferativos Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Prognostic_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article País de afiliación: Japón